Lawrence Honig on TauRx Parses Subgroups to Make the Case for Methylene Blue Derivative, Again
COMMENT The saga of “methylene blue,” or derivatives of this dye with various names, including LMT-X/LMTM and HMTM, continues with a presentation of TauRx-sponsored work at ADPD 2024. The history of this drug, which putatively targets tau aggregation at low doses